We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Lifestyle, pregnancy and epigenetic effects

    Subit Barua

    *Author for correspondence:

    E-mail Address: subitbarua@gmail.com

    Structural Neurobiology Laboratory, Department of Developmental Biochemistry, New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, NY 10314, USA

    &
    Mohammed A Junaid

    Structural Neurobiology Laboratory, Department of Developmental Biochemistry, New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, NY 10314, USA

    Published Online:https://doi.org/10.2217/epi.14.71

    Rapidly growing evidences link maternal lifestyle and prenatal factors with serious health consequences and diseases later in life. Extensive epidemiological studies have identified a number of factors such as diet, stress, gestational diabetes, exposure to tobacco and alcohol during gestation as influencing normal fetal development. In light of recent discoveries, epigenetic mechanisms such as alteration of DNA methylation, chromatin modifications and modulation of gene expression during gestation are believed to possibly account for various types of plasticity such as neural tube defects, autism spectrum disorder, congenital heart defects, oral clefts, allergies and cancer. The purpose of this article is to review a number of published studies to fill the gap in our understanding of how maternal lifestyle and intrauterine environment influence molecular modifications in the offspring, with an emphasis on epigenetic alterations. To support these associations, we highlighted laboratory studies of rodents and epidemiological studies of human based on sampling population cohorts.

    Papers of special note have been highlighted as: • of interest

    References

    • 1 Barker DJ. The origins of the developmental origins theory. J. Intern. Med. 261(5), 412–417 (2007).
    • 2 Barker DJ. The developmental origins of adult disease. J. Am. Coll. Nutr. 23(Suppl.6), s588–s595 (2004).
    • 3 Solomons NW. Developmental origins of health and disease: concepts, caveats, and consequences for public health nutrition. Nutr. Rev. 67(Suppl. 1), s12–s16 (2009).
    • 4 Gluckman PD, Hanson MA, Mitchell MD. Developmental origins of health and disease: reducing the burden of chronic disease in the next generation. Genome Med. 2(2), 14 (2010). doi: 10.1186/gm135.
    • 5 Gluckman PD, Lillycrop KA, Vickers MH et al. Metabolic plasticity during mammalian development is directionally dependent on early nutritional status. Proc. Natl Acad. Sci. USA 104(31), 12796–12800 (2007).
    • 6 Gluckman PD, Hanson MA, Buklijas T, Low FM, Beedle AS. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat. Rev. Endocrinol. 5(7), 401–408 (2009).
    • 7 Barua S, Kuizon S, Junaid MA. Folic acid supplementation in pregnancy and implications in health and disease. J. Biomed. Sci. 21(1), 77 (2014).doi:10.1186/s12929-014-0077-z.• References [7–16] collectively establish role of maternal micronutrients at gestation impact fetal/offsprings epigenetic alterations.
    • 8 Parker SE, Yazdy MM, Tinker SC, Mitchell AA, Werler MM. The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida. Am. J. Obstet. Gynecol. 209(3), 239–238 (2013).
    • 9 Furness D, Fenech M, Dekker G, Khong TY, Roberts C, Hague W. Folate, vitamin B12, vitamin B6 and homocysteine: impact on pregnancy outcome. Matern. Child Nutr. 9(2), 155–166 (2013).
    • 10 Bean LJ, Allen EG, Tinker SW et al. Lack of maternal folic acid supplementation is associated with heart defects in Down syndrome: a report from the National Down Syndrome Project. Birth Defects Res. A Clin. Mol. Teratol. 91(10), 885–893 (2011).
    • 11 O'Neill RJ, Vrana PB, Rosenfeld CS. Maternal methyl supplemented diets and effects on offspring health. Front. Genet. 5, 289 (2014).
    • 12 Rozendaal AM, van Essen AJ, te Meerman GJ et al. Periconceptional folic acid associated with an increased risk of oral clefts relative to non-folate related malformations in the Northern Netherlands: a population based case-control study. Eur. J. Epidemiol. 28(11), 875–887 (2013).
    • 13 Zetstra-van der Woude PA, de Walle HE, Hoek A et al. Maternal high-dose folic acid during pregnancy and asthma medication in the offspring. Pharmacoepidemiol. Drug Saf. 23(10), 1059–1065 (2014).
    • 14 Greenop KR, Miller M, de Klerk NH et al. Maternal dietary intake of folate and vitamins B6 and B12 during pregnancy and risk of childhood brain tumors. Nutr. Cancer 66(5), 800–809 (2014).
    • 15 Burdge GC, Hoile SP, Lillycrop KA. Epigenetics: are there implications for personalised nutrition? Curr. Opin. Clin. Nutr. Metab. Care 15(5), 442–447 (2012).
    • 16 Vanhees K, Vonhogen IG, van Schooten FJ, Godschalk RW. You are what you eat, and so are your children: the impact of micronutrients on the epigenetic programming of offspring. Cell Mol. Life Sci. 71(2), 271–285 (2014).
    • 17 Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J. Nutr. 132(Suppl.8), s2393–s2400 (2002).
    • 18 Waterland RA, Travisano M, Tahiliani KG. Diet-induced hypermethylation at agouti viable yellow is not inherited transgenerationally through the female. FASEB J. 21(12), 3380–3385 (2007).
    • 19 Barua S, Kuizon S, Chadman KK, Flory MJ, Brown WT, Junaid MA. Single-base resolution of mouse offspring brain methylome reveals epigenome modifications caused by gestational folic acid. Epigenetics Chromatin 7(1), 3 (2014).doi: 10.1186/1756-8935-7-3.• References [19,20] establish that higher gestational folic acid induced unbiased alteration in methylation and gene expression in offsprings’ brain epigenome including changes in behavior.
    • 20 Barua S, Chadman KK, Kuizon S et al. Increasing maternal or post-weaning folic acid alters gene expression and moderately changes behavior in the offspring. PLoS ONE 9(7), e101674 (2014).
    • 21 Meethal SV, Hogan KJ, Mayanil CS, Iskandar BJ. Folate and epigenetic mechanisms in neural tube development and defects. Childs Nerv. Syst. 29(9), 1427–1433 (2013).
    • 22 Iskandar BJ, Rizk E, Meier B et al. Folate regulation of axonal regeneration in the rodent central nervous system through DNA methylation. J. Clin. Invest. 120(5), 1603–1616 (2010).
    • 23 Ichi S, Costa FF, Bischof JM et al. Folic acid remodels chromatin on Hes1 and Neurog2 promoters during caudal neural tube development. J. Biol. Chem. 285(47), 36922–36932 (2010).
    • 24 Dunn GA, Bale TL. Maternal high-fat diet promotes body length increases and insulin insensitivity in second-generation mice. Endocrinology 150(11), 4999–5009 (2009).
    • 25 Pruis MG, Lendvai A, Bloks VW et al. Maternal western diet primes non-alcoholic fatty liver disease in adult mouse offspring. Acta Physiol. (Oxf.) 210(1), 215–227 (2014).
    • 26 Strakovsky RS, Zhang X, Zhou D, Pan YX. The regulation of hepatic Pon1 by a maternal high-fat diet is gender specific and may occur through promoter histone modifications in neonatal rats. J. Nutr. Biochem. 25(2), 170–176 (2014).
    • 27 Suter M, Bocock P, Showalter L et al. Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primates. FASEB J. 25(2), 714–726 (2011).
    • 28 Begum G, Stevens A, Smith EB et al. Epigenetic changes in fetal hypothalamic energy regulating pathways are associated with maternal undernutrition and twinning. FASEB J. 26(4), 1694–1703 (2012).
    • 29 Altmann S, Murani E, Schwerin M, Metges CC, Wimmers K, Ponsuksili S. Maternal dietary protein restriction and excess affects offspring gene expression and methylation of non-SMC subunits of condensin I in liver and skeletal muscle. Epigenetics 7(3), 239–252 (2012).
    • 30 Takaya J, Iharada A, Okihana H, Kaneko K. Magnesium deficiency in pregnant rats alters methylation of specific cytosines in the hepatic hydroxysteroid dehydrogenase-2 promoter of the offspring. Epigenetics 6(5), 573–578 (2011).
    • 31 Roseboom TJ, van der Meulen JH, Ravelli AC, Osmond C, Barker DJ, Bleker OP. Effects of prenatal exposure to the Dutch famine on adult disease in later life: an overview. Mol. Cell Endocrinol. 185(1–2), 93–98 (2001).• References [31–33, 37] collectively establish that malnutrition or prenatal exposure to famine results epigenetic alterations and associated with diseases in later life.
    • 32 Heijmans BT, Tobi EW, Stein AD et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl Acad. Sci. USA 105(44), 17046–17049 (2008).
    • 33 Lumey LH, Stein AD, Kahn HS et al. Cohort profile: the Dutch Hunger Winter families study. Int. J. Epidemiol. 36(6), 1196–1204 (2007).
    • 34 Bygren LO, Edvinsson S, Brostrom G. Change in food availability during pregnancy: is it related to adult sudden death from cerebro- and cardiovascular disease in offspring? Am. J. Hum. Biol. 12(4), 447–453 (2000).
    • 35 Brown AS, Susser ES. Sex differences in prevalence of congenital neural defects after periconceptional famine exposure. Epidemiology 8(1), 55–58 (1997).
    • 36 Susser E, Neugebauer R, Hoek HW et al. Schizophrenia after prenatal famine. Further evidence. Arch. Gen. Psychiatry 53(1), 25–31 (1996).
    • 37 Tobi EW, Lumey LH, Talens RP et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum. Mol. Genet. 18(21), 4046–4053 (2009).
    • 38 Tobi EW, Heijmans BT, Kremer D et al. DNA methylation of IGF2, GNASAS, INSIGF and LEP and being born small for gestational age. Epigenetics 6(2), 171–176 (2011).
    • 39 Hughes LA, van den Brandt PA, de Bruine AP et al. Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms. PLoS ONE 4(11), e7951 (2009).
    • 40 Stein AD, Pierik FH, Verrips GH, Susser ES, Lumey LH. Maternal exposure to the Dutch famine before conception and during pregnancy: quality of life and depressive symptoms in adult offspring. Epidemiology 20(6), 909–915 (2009).
    • 41 World Health Organization. Obesity and overweight. www.who.int/mediacentre/factsheets/fs311/en/Fact sheet N°311 (2014).
    • 42 Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology 132(6), 2087–2102 (2007).
    • 43 Li CC, Young PE, Maloney CA et al. Maternal obesity and diabetes induces latent metabolic defects and widespread epigenetic changes in isogenic mice. Epigenetics 8(6), 602–611 (2013).• References [43, 54, 56 and 57] collectively show that maternal obesity and diabetes induce metabolic diseases in offspring possibly through epigenetic alterations.
    • 44 Alfaradhi MZ, Ozanne SE. Developmental programming in response to maternal overnutrition. Front. Genet. 2, 27 (2011).
    • 45 Mingrone G, Manco M, Mora ME et al. Influence of maternal obesity on insulin sensitivity and secretion in offspring. Diabetes Care 31(9), 1872–1876 (2008).
    • 46 Lehnen H, Zechner U, Haaf T. Epigenetics of gestational diabetes mellitus and offspring health: the time for action is in early stages of life. Mol. Hum. Reprod. 19(7), 415–422 (2013).
    • 47 del Rosario MC, Ossowski V, Knowler WC, Bogardus C, Baier LJ, Hanson RL. Potential epigenetic dysregulation of genes associated with MODY and type 2 diabetes in humans exposed to a diabetic intrauterine environment: an analysis of genome-wide DNA methylation. Metabolism 63(5), 654–660 (2014).
    • 48 Sumathipala D, Gamage T, Wijesiriwardena B, Jayasekara RW, Dissanayake VH. An infant born to a mother with gestational diabetes presenting with 49, XXXXY syndrome and renal agenesis-a case report. J. Clin. Res. Pediatr. Endocrinol. 4(4), 223–225 (2012).
    • 49 Cedergren M. Effects of gestational weight gain and body mass index on obstetric outcome in Sweden. Int. J. Gynaecol. Obstet. 93(3), 269–274 (2006).
    • 50 Frederick IO, Rudra CB, Miller RS, Foster JC, Williams MA. Adult weight change, weight cycling, and prepregnancy obesity in relation to risk of preeclampsia. Epidemiology 17(4), 428–434 (2006).
    • 51 Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am. J. Obstet. Gynecol. 192(4), 989–997 (2005).
    • 52 Silverman BL, Rizzo TA, Cho NH, Metzger BE. Long-term effects of the intrauterine environment. The Northwestern University diabetes in pregnancy center. Diabetes Care 21(Suppl. 2), B142–B149 (1998).
    • 53 Godfrey KM, Sheppard A, Gluckman PD et al. Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes 60(5), 1528–1534 (2011).
    • 54 Yang QY, Liang JF, Rogers CJ, Zhao JX, Zhu MJ, Du M. Maternal obesity induces epigenetic modifications to facilitate Zfp423 expression and enhance adipogenic differentiation in fetal mice. Diabetes 62(11), 3727–3735 (2013).
    • 55 Cannon MV, Buchner DA, Hester J et al. Maternal nutrition induces pervasive gene expression changes but no detectable DNA methylation differences in the liver of adult offspring. PLoS ONE 9(3), e90335 (2014).• Reference [55] shows that maternal nutrition alters the expression of several gene in the liver of offspring with no differences in DNA methylation.
    • 56 Ruchat SM, Houde AA, Voisin G et al. Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics 8(9), 935–943 (2013).
    • 57 West NA, Kechris K, Dabelea D. Exposure to maternal diabetes in utero and DNA methylation patterns in the offspring. Immunometabolism 1, 1–9 (2013).
    • 58 Lester BM, Conradt E, Marsit CJ. Epigenetic basis for the development of depression in children. Clin. Obstet. Gynecol. 56(3), 556–565 (2013).
    • 59 Gudsnuk K, Champagne FA. Epigenetic influence of stress and the social environment. ILAR. J. 53(3–4), 279–288 (2012).
    • 60 Euker JS, Riegle GD. Effects of stress on pregnancy in the rat. J. Reprod. Fertil. 34(2), 343–346 (1973).
    • 61 Guo A, Nappi RE, Criscuolo M et al. Effect of chronic intermittent stress on rat pregnancy and postnatal development. Eur. J. Obstet. Gynecol. Reprod. Biol. 51(1), 41–45 (1993).
    • 62 Mulligan CJ, D'Errico NC, Stees J, Hughes DA. Methylation changes at NR3C1 in newborns associate with maternal prenatal stress exposure and newborn birth weight. Epigenetics 7(8), 853–857 (2012).
    • 63 Barbazanges A, Piazza PV, Le Moal M, Maccari S. Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J. Neurosci. 16(12), 3943–3949 (1996).
    • 64 Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 3(2), 97–106 (2008).
    • 65 Hompes T, Izzi B, Gellens E et al. Investigating the influence of maternal cortisol and emotional state during pregnancy on the DNA methylation status of the glucocorticoid receptor gene (NR3C1) promoter region in cord blood. J. Psychiatr. Res. 47(7), 880–891 (2013).
    • 66 Boersma GJ, Lee RS, Cordner ZA et al. Prenatal stress decreases BDNF expression and increases methylation of BDNF exon IV in rats. Epigenetics 9(3), 437–447 (2014).• References [66–68] collectively establish that prenatal stress induces alteration in methylation and gene expression in offsprings’ brain epigenome.
    • 67 Monteleone MC, Adrover E, Pallares ME, Antonelli MC, Frasch AC, Brocco MA. Prenatal stress changes the glycoprotein GPM6A gene expression and induces epigenetic changes in rat offspring brain. Epigenetics 9(1), 152–160 (2014).
    • 68 Van den Hove DL, Kenis G, Brass A et al. Vulnerability versus resilience to prenatal stress in male and female rats; implications from gene expression profiles in the hippocampus and frontal cortex. Eur. Neuropsychopharmacol. 23(10), 1226–1246 (2013).
    • 69 Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged ≥ =18 years‐United States, 2005–2010. MMWR Morb. Mortal. Wkly. Rep. 60(35), 1207–1212 (2011).
    • 70 Centers for Disease Control and Prevention (CDC). Adult cigarette smoking in the United States: current estimates. www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/ (2014).
    • 71 American Lung Association. Women and tobacco use. www.lung.org/stop-smoking/about-smoking/facts-figures/women-and-tobacco-use.html#1 (2014).
    • 72 Centers for Disease Control and Prevention (CDC). Tobacco use and pregnancy. www.cdc.gov/Reproductivehealth/TobaccoUsePregnancy/index.htm (2014).
    • 73 Suter M, Abramovici A, Aagaard-Tillery K. Genetic and epigenetic influences associated with intrauterine growth restriction due to in utero tobacco exposure. Pediatr. Endocrinol. Rev. 8(2), 94–102 (2010).
    • 74 Kyrklund-Blomberg NB, Cnattingius S. Preterm birth and maternal smoking: risks related to gestational age and onset of delivery. Am. J. Obstet. Gynecol. 179(4), 1051–1055 (1998).
    • 75 Hammoud AO, Bujold E, Sorokin Y, Schild C, Krapp M, Baumann P. Smoking in pregnancy revisited: findings from a large population-based study. Am. J. Obstet. Gynecol. 192(6), 1856–1862 (2005).
    • 76 Aagaard-Tillery KM, Porter TF, Lane RH, Varner MW, Lacoursiere DY. In utero tobacco exposure is associated with modified effects of maternal factors on fetal growth. Am. J. Obstet. Gynecol. 198(1), 66.e1–66.e6 (2008).
    • 77 Maccani JZ, Koestler DC, Houseman EA, Marsit CJ, Kelsey KT. Placental DNA methylation alterations associated with maternal tobacco smoking at the RUNX3 gene are also associated with gestational age. Epigenomics 5(6), 619–630 (2013).
    • 78 Suter M, Abramovici A, Showalter L et al. In utero tobacco exposure epigenetically modifies placental CYP1A1 expression. Metabolism 59(10), 1481–1490 (2010).
    • 79 Wang X, Zuckerman B, Pearson C et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 287(2), 195–202 (2002).
    • 80 Choi H, Jedrychowski W, Spengler J et al. International studies of prenatal exposure to polycyclic aromatic hydrocarbons and fetal growth. Environ. Health Perspect. 114(11), 1744–1750 (2006).
    • 81 Perera FP, Tang D, Rauh V et al. Relationship between polycyclic aromatic hydrocarbon-DNA adducts, environmental tobacco smoke, and child development in the World Trade Center cohort. Environ. Health Perspect. 115(10), 1497–1502 (2007).
    • 82 Suter M, Ma J, Harris A et al. Maternal tobacco use modestly alters correlated epigenome-wide placental DNA methylation and gene expression. Epigenetics 6(11), 1284–1294 (2011).
    • 83 Markunas CA, Xu Z, Harlid S et al. Identification of DNA methylation changes in newborns related to maternal smoking during pregnancy. Environ. Health Perspect. 122(10), 1147–1153 (2014).
    • 84 Breton CV, Byun HM, Wenten M, Pan F, Yang A, Gilliland FD. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am. J. Respir. Crit Care Med. 180(5), 462–467 (2009).
    • 85 Wilhelm-Benartzi CS, Houseman EA, Maccani MA et al. In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta. Environ. Health Perspect. 120(2), 296–302 (2012).
    • 86 Toledo-Rodriguez M, Lotfipour S, Leonard G et al. Maternal smoking during pregnancy is associated with epigenetic modifications of the brain-derived neurotrophic factor-6 exon in adolescent offspring. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B(7), 1350–1354 (2010).
    • 87 Knopik VS, Maccani MA, Francazio S, McGeary JE. The epigenetics of maternal cigarette smoking during pregnancy and effects on child development. Dev. Psychopathol. 24(4), 1377–1390 (2012).
    • 88 Koob GF. Alcoholism: allostasis and beyond. Alcohol Clin. Exp. Res. 27(2), 232–243 (2003).
    • 89 Pandey SC. Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol. Sci. 24(9), 456–460 (2003).
    • 90 Jones KL, Smith DW, Ulleland CN, Streissguth P. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1(7815), 1267–1271 (1973).
    • 91 May PA, Gossage JP. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res. Health 25(3), 159–167 (2001).
    • 92 Resendiz M, Chen Y, Ozturk NC, Zhou FC. Epigenetic medicine and fetal alcohol spectrum disorders. Epigenomics 5(1), 73–86 (2013).
    • 93 Bhatara V, Loudenberg R, Ellis R. Association of attention deficit hyperactivity disorder and gestational alcohol exposure: an exploratory study. J. Atten. Disord. 9(3), 515–522 (2006).
    • 94 Hellemans KG, Verma P, Yoon E, Yu W, Weinberg J.Prenatal alcohol exposure increases vulnerability to stress and anxiety-like disorders in adulthood. Ann. NY Acad. Sci. 1144, 154–175 (2008).doi: 10.1196/annals.1418.016.
    • 95 Perkins A, Lehmann C, Lawrence RC, Kelly SJ. Alcohol exposure during development: Impact on the epigenome. Int. J. Dev. Neurosci. 31(6), 391–397 (2013).
    • 96 Liu Y, Balaraman Y, Wang G, Nephew KP, Zhou FC. Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation. Epigenetics 4(7), 500–511 (2009).• References [96,97] show that gestational alcohol exposure alters the early neurulation, phenotype and epigenotype of offspring.
    • 97 Kaminen-Ahola N, Ahola A, Maga M et al. Maternal ethanol consumption alters the epigenotype and the phenotype of offspring in a mouse model. PLoS Genet. 6(1), e1000811 (2010).
    • 98 Latham KE, Sapienza C, Engel N. The epigenetic lorax: gene-environment interactions in human health. Epigenomics 4(4), 383–402 (2012).
    • 99 Suk WA, Murray K, Avakian MD. Environmental hazards to children's health in the modern world. Mutat. Res. 544(2–3), 235–242 (2003).
    • 100 Anway MD, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors. Endocrinology 147(Suppl.6), s43–s49 (2006).
    • 101 Betancourt AM, Eltoum IA, Desmond RA, Russo J, Lamartiniere CA. In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat. Environ. Health Perspect. 118(11), 1614–1619 (2010).
    • 102 Volberg V, Harley K, Calafat AM et al. Maternal bisphenol a exposure during pregnancy and its association with adipokines in Mexican-American children. Environ. Mol. Mutagen. 54(8), 621–628 (2013).
    • 103 Miao M, Yuan W, He Y et al. In utero exposure to bisphenol-A and anogenital distance of male offspring. Birth Defects Res. A Clin. Mol. Teratol. 91(10), 867–872 (2011).
    • 104 Harley KG, Gunier RB, Kogut K et al. Prenatal and early childhood bisphenol A concentrations and behavior in school-aged children. Environ. Res. 126, 43–50 (2013).
    • 105 Kuwahara R, Kawaguchi S, Kohara Y, Cui H, Yamashita K. Perinatal exposure to low-dose bisphenol A impairs spatial learning and memory in male rats. J. Pharmacol. Sci. 123(2), 132–139 (2013).
    • 106 Poimenova A, Markaki E, Rahiotis C, Kitraki E. Corticosterone-regulated actions in the rat brain are affected by perinatal exposure to low dose of bisphenol A. Neuroscience 167(3), 741–749 (2010).
    • 107 Xu XH, Zhang J, Wang YM, Ye YP, Luo QQ. Perinatal exposure to bisphenol-A impairs learning-memory by concomitant down-regulation of N-methyl-D-aspartate receptors of hippocampus in male offspring mice. Horm. Behav. 58(2), 326–333 (2010).
    • 108 Goncalves CR, Cunha RW, Barros DM, Martinez PE. Effects of prenatal and postnatal exposure to a low dose of bisphenol A on behavior and memory in rats. Environ. Toxicol. Pharmacol. 30(2), 195–201 (2010).
    • 109 Elsworth JD, Jentsch JD, Vandevoort CA, Roth RH, Jr DE, Leranth C. Prenatal exposure to bisphenol A impacts midbrain dopamine neurons and hippocampal spine synapses in non-human primates. Neurotoxicology 35, 113–120 (2013).
    • 110 Fujimoto T, Kubo K, Nishikawa Y, Aou S. Postnatal exposure to low-dose bisphenol A influences various emotional conditions. J. Toxicol. Sci. 38(4), 539–546 (2013).
    • 111 Susiarjo M, Sasson I, Mesaros C, Bartolomei MS. Bisphenol a exposure disrupts genomic imprinting in the mouse. PLoS Genet. 9(4), e1003401 (2013).• References [111–115 and 117–121] show that in utero exposure to environmental epigenome endocrine disruptors such as BPA, genistein, diethylstilbestrol modifies the fetal epigenome and some of such changes are transgenerational.
    • 112 Kundakovic M, Gudsnuk K, Franks B et al. Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proc. Natl Acad. Sci. USA 110(24), 9956–9961 (2013).
    • 113 Jang YJ, Park HR, Kim TH et al. High dose bisphenol A impairs hippocampal neurogenesis in female mice across generations. Toxicology 296(1–3), 73–82 (2012).
    • 114 Yaoi T, Itoh K, Nakamura K, Ogi H, Fujiwara Y, Fushiki S. Genome-wide analysis of epigenomic alterations in fetal mouse forebrain after exposure to low doses of bisphenol A. Biochem. Biophys. Res. Commun. 376(3), 563–567 (2008).
    • 115 Gore AC, Walker DM, Zama AM, Armenti AE, Uzumcu M. Early life exposure to endocrine-disrupting chemicals causes lifelong molecular reprogramming of the hypothalamus and premature reproductive aging. Mol. Endocrinol. 25(12), 2157–2168 (2011).
    • 116 Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284(15), 878–881 (1971).
    • 117 Doherty LF, Bromer JG, Zhou Y, Aldad TS, Taylor HS. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Horm. Cancer 1(3), 146–155 (2010).
    • 118 Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect. 114(4), 567–572 (2006).
    • 119 Vanhees K, Coort S, Ruijters EJ, Godschalk RW, van Schooten FJ, Barjesteh van Waalwijk van Doorn-Khosrovani. Epigenetics: prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage. FASEB J. 25(2), 797–807 (2011).
    • 120 Skinner MK, Anway MD, Savenkova MI, Gore AC, Crews D. Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PLoS ONE 3(11), e3745 (2008).
    • 121 Crews D, Gillette R, Scarpino SV, Manikkam M, Savenkova MI, Skinner MK. Epigenetic transgenerational inheritance of altered stress responses. Proc. Natl Acad. Sci. USA 109(23), 9143–9148 (2012).
    • 122 Gillott A, Standen PJ. Levels of anxiety and sources of stress in adults with autism. J. Intellect. Disabil. 11(4), 359–370 (2007).
    • 123 Koenig JI, Kirkpatrick B, Lee P. Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 27(2), 309–318 (2002).
    • 124 Mueller BR, Bale TL. Impact of prenatal stress on long term body weight is dependent on timing and maternal sensitivity. Physiol. Behav. 88(4–5), 605–614 (2006).
    • 125 Mueller BR, Bale TL. Sex-specific programming of offspring emotionality after stress early in pregnancy. J. Neurosci. 28(36), 9055–9065 (2008).
    • 126 Gallou-Kabani C, Gabory A, Tost J et al. Sex- and diet-specific changes of imprinted gene expression and DNA methylation in mouse placenta under a high-fat diet. PLoS ONE 5(12), e14398 (2010).
    • 127 Muralimanoharan S, Maloyan A, Myatt L. Evidence of sexual dimorphism in the placental function with severe preeclampsia. Placenta 34(12), 1183–1189 (2013).
    • 128 Clifton VL, Hodyl NA, Murphy VE, Giles WB, Baxter RC, Smith R. Effect of maternal asthma, inhaled glucocorticoids and cigarette use during pregnancy on the newborn insulin-like growth factor axis. Growth Horm. IGF. Res. 20(1), 39–48 (2010).
    • 129 Tobi EW, Lumey LH, Talens RP et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum. Mol. Genet 18(21), 4046–4053 (2009).
    • 130 Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 293(5532), 1089–1093 (2001).
    • 131 Wossidlo M, Nakamura T, Lepikhov K et al. 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat. Commun. 2, 241 (2011).• Reference [131] shows that DNA methylation reprogramming in the mammalian zygote is modulated by 5hmC and Tet3.
    • 132 Jiang X, Yan J, West AA et al. Maternal choline intake alters the epigenetic state of fetal cortisol-regulating genes in humans. FASEB J. 26(8), 3563–3574 (2012).
    • 133 Boeke CE, Baccarelli A, Kleinman KP et al. Gestational intake of methyl donors and global LINE-1 DNA methylation in maternal and cord blood: prospective results from a folate-replete population. Epigenetics 7(3), 253–260 (2012).
    • 134 Ba Y, Yu H, Liu F et al. Relationship of folate, vitamin B12 and methylation of insulin-like growth factor-II in maternal and cord blood. Eur. J. Clin. Nutr. 65(4), 480–485 (2011).
    • 135 Hoyo C, Murtha AP, Schildkraut JM et al. Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy. Epigenetics 6(7), 928–936 (2011).
    • 136 El Hajj N, Pliushch G, Schneider E et al. Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus. Diabetes 62(4), 1320–1328 (2013).
    • 137 Bouchard L, Hivert MF, Guay SP, St Pierre J, Perron P, Brisson D. Placental adiponectin gene DNA methylation levels are associated with mothers’ blood glucose concentration. Diabetes 61(5), 1272–1280 (2012).
    • 138 Non AL, Binder AM, Kubzansky LD, Michels KB. Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy. Epigenetics 9(7), 964–972 (2014).
    • 139 Soubry A, Murphy S, Huang Z et al. The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring. Clin. Epigenetics 3, 2 (2011).
    • 140 Joubert BR, Haberg SE, Bell DA et al. Maternal smoking and DNA methylation in newborns: in utero effect or epigenetic inheritance? Cancer Epidemiol. Biomarkers Prev. 23(6), 1007–1017 (2014).
    • 141 Patil VK, Holloway JW, Zhang H et al. Interaction of prenatal maternal smoking, interleukin 13 genetic variants and DNA methylation influencing airflow and airway reactivity. Clin. Epigenetics 5(1), 22 (2013).
    • 142 Joubert BR, Haberg SE, Nilsen RM et al. 450K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ. Health Perspect. 120(10), 1425–1431 (2012).
    • 143 Murphy SK, Adigun A, Huang Z et al. Gender-specific methylation differences in relation to prenatal exposure to cigarette smoke. Gene 494(1), 36–43 (2012).
    • 144 Breton CV, Salam MT, Gilliland FD. Heritability and role for the environment in DNA methylation in AXL receptor tyrosine kinase. Epigenetics 6(7), 895–898 (2011).